These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met? Krajnc M; Kravos Tramšek NA Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852 [TBL] [Abstract][Full Text] [Related]
3. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control. Yoshii H; Mita T; Katakami N; Okada Y; Osonoi T; Aso K; Kurozumi A; Wakasugi S; Sato F; Ishii R; Gosho M; Shimomura I; Watada H J Clin Endocrinol Metab; 2022 Sep; 107(10):e3990-e4003. PubMed ID: 35908248 [TBL] [Abstract][Full Text] [Related]
4. Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study. Eliasson B; Allansson Kjölhede E; Salö S; Fabrin Nielsen N; Eeg-Olofsson K Diabetes Ther; 2024 Jun; 15(6):1301-1312. PubMed ID: 38598054 [TBL] [Abstract][Full Text] [Related]
5. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes. Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500 [TBL] [Abstract][Full Text] [Related]
6. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis. Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z Front Public Health; 2022; 10():990281. PubMed ID: 36091534 [TBL] [Abstract][Full Text] [Related]
7. Switching from Multiple Insulin Injections to a Fixed Combination of Degludec and Liraglutide in Patients with Type 2 Diabetes Mellitus: Results from the Simplify Study After 6 Months. Martinka E; Dravecká I; Tkáč I Diabetes Ther; 2023 Sep; 14(9):1503-1515. PubMed ID: 37402960 [TBL] [Abstract][Full Text] [Related]
8. Beyond HbA1c: Identifying Gaps in Glycemic Control Among Children and Young People with Type 1 Diabetes Using Continuous Glucose Monitoring. Tandon A; Bhowmik E; Ali Z; Tripathi S; Bk A; Dabadghao P; Sudhanshu S; Bhatia V Indian J Pediatr; 2024 Apr; ():. PubMed ID: 38639860 [TBL] [Abstract][Full Text] [Related]
9. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes. Irace C; Cutruzzolà A; Nuzzi A; Assaloni R; Brunato B; Pitocco D; Tartaglione L; Di Molfetta S; Cignarelli A; Laviola L; Citro G; Lovati E; Gnasso A; Tweden KS; Kaufman FR Diabetes Obes Metab; 2020 Jul; 22(7):1056-1061. PubMed ID: 32037699 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes. Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494 [No Abstract] [Full Text] [Related]
11. Good Metabolic Control in Children with Type 1 Diabetes Mellitus: Does Glycated Hemoglobin Correlate with Interstitial Glucose Monitoring Using FreeStyle Libre? Porcel-Chacón R; Antúnez-Fernández C; Mora Loro M; Ariza-Jimenez AB; Tapia Ceballos L; Jimenez Hinojosa JM; Lopez-Siguero JP; Leiva Gea I J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768429 [TBL] [Abstract][Full Text] [Related]
12. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials. Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858 [TBL] [Abstract][Full Text] [Related]
13. Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes. Leite SAO; Silva MP; Lavalle ACR; Bertogy MCV; Bastos M; Kuklik SCV; Umpierrez G Diabetol Metab Syndr; 2023 Nov; 15(1):240. PubMed ID: 37993898 [TBL] [Abstract][Full Text] [Related]
14. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL. Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500 [TBL] [Abstract][Full Text] [Related]
15. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting. Oriot P; Hermans MP J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333 [TBL] [Abstract][Full Text] [Related]